​

Funding Round

Series F - Benvenue Medical

Series F - Benvenue Medical

Investment Firm

Overview

Benvenue Medical is a biotech company developing innovative and minimally invasive surgical solutions for the treatment of spinal disorders.

Announced Date

Jan 07, 2016

Funding Type

Series F

Highlights

Location

United States, North America

Social

Investor Lead

Versant Ventures

Versant Ventures

Versant Ventures is a early_stage_venture and late_stage_venture and post_ipo firm.

Participant Investors

6

Investor Name
Participant InvestorInterWest Partners
Participant InvestorDomain Associates
Participant InvestorVersant Ventures
Participant InvestorTechnology Partners
Participant InvestorDeNovo Ventures

Round Details and Background

Benvenue Medical raised $23000000 on 2016-01-07 in Series F

Benvenue Medical is a biotech company developing innovative and minimally invasive surgical solutions for the treatment of spinal disorders.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 31, 2011
Debt Financing - Benvenue Medical
-350.0K
Jun 28, 2012
Series D - Benvenue Medical
4-25.0M
Apr 18, 2011
Series C - Benvenue Medical
4-35.5M
Jan 07, 2008
Series B - Benvenue Medical
3-15.0M

Recent Activity

There is no recent news or activity for this profile.